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In this study aqueous extracts from salal berry (SB) and blackcurrant pomace (BCP)
were used to reformulate yogurt and the anti-diabetic properties of the beverage
were investigated during 4 weeks of cold storage at 4 C. Results indicated that
a-amylase, a-glucosidase and DPP-IV inhibitory activities increased with storage
time for all samples. At the end of storage period a-amylase, a-glucosidase and
DPP-IV inhibition were >61%, 62% and 56% respectively for all yogurt types.
This increase in bioactivity during cold storage is attributed to the viability of
lactic acid bacteria (w108 cfu/g), which is maintained for 4 weeks. Enzyme
inhibition increased similarly for all yogurt types at 4 C except for a-
glucosidase. Yogurt with BCP showed the highest potency to inhibit a-
glucosidase (>90%) with an IC50 value of 0.20 mg/ml (week 4). A peptidomic
approach based on liquid chromatography coupled with mass spectrometry (LC-
MS) was used for the separation and identiﬁcation of peptides generated in three
types of yogurt. A total of 486 peptides mainly from caseins were identiﬁed, of.e00875
lished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
y-nc-nd/4.0/).
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ACE-inhibitors.
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1. Introduction
Yogurt is one of the most popular dairy products which is produced from the acid
coagulation of milk proteins during fermentation by lactic acid bacteria, typically
Lactobacillus bulgaricus and Streptococcus thermophilus (Gharibzahedi and
Chronakis, 2018). The popularity of yogurt is primarily owed to its sensory proper-
ties, which are appreciated widely by consumers around the world, in addition to its
well-established nutritional value (Pereira, 2014). Yogurt may exert beneﬁcial ef-
fects on metabolic health by controlling body weight, energy homeostasis and gly-
cemic control and is therefore often considered a functional food with health-
promoting and disease-preventing properties (Panahi et al., 2017). The latter are
largely attributed to the addition of probiotic bacteria and/or the release of a range
of bioactive peptides (Oliveira et al., 2015; Morell et al., 2017). The bioactive pep-
tides identiﬁed in yogurt derive predominantly from the proteolytic action of lactic
acid bacteria on milk proteins and have a wide range of physiological activities such
as antihypertensive, antioxidant, antithrombotic, opioid, antimicrobial, cytomodula-
tory, immuno-modulatory, and miscellaneous peptides (Mann et al., 2017). These
functions relate to human wellness or a reduced risk of certain chronic diseases.
Type 2 diabetes (T2D) is a chronic metabolic disorder that occurs either due to defec-
tive insulin production or action and is typically manifested by elevated sugar levels
in blood, formerly known as hyperglycemia. Consumption of dairy proteins has been
linked with serum glucose regulatory properties in humans, which is attributable to
the action of bioactive peptides released during gastrointestinal digestion (Lacroix
and Li-Chan, 2013). Milk-protein derived peptides can simulate the secretion of
gut-derived hormones and/or inhibit enzymes involved in glycaemia homeostasis
such as dipeptidyl peptidase IV (DPP-IV), a-amylase and a-glucosidase (Mann
et al., 2017). The structural properties, gastrointestinal fate, absorption, bioavail-
ability and mode of action of milk-protein derived peptides in relation to T2D regu-
lation has been described in detail (Oseguera-Toledo et al., 2014; Patil et al., 2015).
In recent decades, yogurt recipe has diversiﬁed in response to consumers’ demands
for healthier and tastier products, which led to the development of a range of prod-
ucts acquiring diﬀerent ﬂavors, consistencies and texture (Morell et al., 2015). In
particular, the inclusion of fruits in yogurt recipe, either at industrial scale or domes-
tically, is one of the common practices adopted in yogurt-making. Meanwhile, the
addition of fruits or fruits extracts has a major impact on the physico-chemicalon.2018.e00875
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and relates to its nutrient and non-nutrient composition. For instance, commonly
added fruits to yogurts such as berries, are good sources of phenolic compounds
(Matilla et al., 2006). These in turn are known to interact with milk proteins and
form protein-polyphenol complexes (Charlton et al., 2002). These type of interac-
tions, which are mediated predominantly by hydrophobic bonding between amino
acid side chains and polyphenol aromatic rings and to a lesser extent by hydrogen
or covalent bonding, determine the bioaccessibility and thus bioavailability of the
ingested nutrients (Jakobek, 2015). Furthermore, molecular interactions between
proteins and polyphenols may aﬀect the susceptibility of the former to proteolytic
activity by fermenting bacteria or digestive enzymes during passage through the
gastrointestinal tract.
Salal (Gaultheria shallon) and blackcurrant (Ribes nigrum) are both common fruits
in Scotland, which although novel and underutilized respectively, show potential for
food applications due to their phenolic composition (McDougall et al., 2016). In this
research, the eﬀect of yogurt reformulation with SB and BCP extract on the inhibi-
tion of key enzymes for T2D management was monitored during refrigerated stor-
age. An “omic” approach including peptidomics and proteomics was adopted to
identify bioactive peptides from the soluble fraction and monitor changes in whey
protein electrophoretic mobility between reformulated and plain yogurt. Thus, the
objective of the present study was to correlate T2D enzyme inhibitory activities
with bovine milk-derived bioactive peptides released from yogurt reformulated
with aqueous berry extracts. Results can be used to identify functional food ingredi-
ents for the management of type 2 diabetes.2. Materials and methods
2.1. Materials
Dried skimmed cow’s milk powder (SMP) Marvel brand, was obtained from Tesco
supermarket (Aberdeen, UK). Freeze-dried yogurt starter culture containing Lacto-
bacillus bulgaricus and Streptococcus thermophilus (Goat Nutrition Ltd., Ashford,
England) was used to prepare yogurt starter. Dried and powdered SB and BCP were
kindly donated by James Hutton Institute (Dundee, Scotland). Pure Whey IsolateTM
97 powder (WPI) was used as emulsiﬁer and was purchased from Bulk Powders
(Colchester, UK). A-glucosidase type I from baker’s yeast, amylase activity assay,
L-Serine and O-Phthaldialdehyde reagent solution was purchased from Sigma-
Aldrich (Dorset, UK). Amicon Ultra-0.5 (3kDa) centrifugal ﬁlter units were pur-
chased from Sigma-Aldrich (Dorset, UK). Precast gels and all reagents used for pro-
tein electrophoresis were purchased from Bio-Rad Laboratories Ltd (Hertfordshire,
UK). All other reagents used were of analytical grade.on.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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beverages
80 ml of puriﬁed water was added to 8 g of fruit for preparing each aqueous extract.
The extracts were mixed for 1 h on a Stuart SRT6 tube roller (Cole-Palmer, Staﬀord-
shire, UK) at room temperature and then centrifuged at 2290 x g for 15 min using an
EppendorfTM 5702R (Fisher Scientiﬁc, Loughborough, UK). The supernatant was
collected and ﬁltered with butter muslin squares (Lakeland, Aberdeen, UK) to re-
move any residues. The extraction process was repeated 3 times and liquid extracts
were combined and stored at -20 C.
Yogurt was made up to 0.5 kg for each sample using milk powder, ﬁltered water,
freshly prepared yogurt starter and aqueous fruit extracts. Yogurt starter was pre-
pared by dissolving the freeze-dried culture (5 g) in 840 g of water and adding
155 g of SMP (0.5 g lactic culture/100 g milk). The recipe for all samples included
16% (w/w) of dried milk powder and 3% (w/w) of yogurt starter. 20% (w/w) of fruit
extract in liquid form was added to the reformulated samples and the water content
was adjusted accordingly for the control sample. Yogurt mixes (milk powder, water
and fruit extracts if applicable) were heated to 80 C for 10 min and then immedi-
ately cooled down to a temperature of approximately 45 C. This was followed
by the addition of the 30g of yogurt starter to the mixes. Samples were then poured
in a sterile container and placed in a yogurt fermenter (Lakeland, Aberdeen, UK) set
at 44 C. A portable food and dairy pH meter (Hanna Instruments Ltd, Leighton
Buzzard, UK) was used to measure the changes in pH of the samples during fermen-
tation on an hourly basis until a pH of 4.5 was reached. At the end of the fermenta-
tion process samples were diluted (1:1) on a weight basis and samples were then
processed in a single stage valve homogenizer (APV-1000, SPX Flow Technology,
West Sussex, UK). Each sample was passed twice through the homogenizer to
ensure complete homogenization. Homogenization pressure was set at 50 bar for
both the passages through the homogenizing valve. Two diﬀerent batches for every
yogurt beverage (500 g) were prepared, which were stored at 4 C for 4 weeks. Sam-
pling was performed on a weekly basis for subsequent analysis. Samples were centri-
fuged at 13,000 x g for 10 min using an Eppendorf MiniSpin Plus (Sigma-
Aldrich, MO, USA) and the supernatant (aqueous extract) was used for all subse-
quent analyses.2.3. Total phenol assay of dried SB and BCP
Powdered dried sample (0.8 g) was extracted with 19.2 ml ethanol (50%) for 2 h with
shaking at room temperature. After centrifugation at 3220  g (Eppendorf 5810R,
Fisher Scientiﬁc, Loughborough, UK) for 1 h at 4 C, the supernatant was collected
and the extraction was repeated one more time. The supernatants were combined and
dried using a rotary evaporator (Rotavapor R-114, B€uchi Labortechnik AG,on.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
5 https://doi.org/10.1016/j.heliy
2405-8440/ 2018 The Auth
(http://creativecommons.org/li
Article Nowe00875Switzerland) and the remaining solution was freeze-dried (FreeZone, Labconco Cor-
poration, MO, USA). The dried extract was reconstituted in DMSO (100%) at 200
mg/ml, aliquoted and stored at -20 C until analyzed. YE were used for all analyses
unless otherwise stated. Phenol content was measured using a modiﬁed
FolineCiocalteau method (Deighton et al., 2000). In brief, 50 ml of extract were
mixed with 250 ml ml of FolineCiocalteu reagent and incubated at room temperature
for 1 min. Following the addition of 200 ml of 7.5 % (w/v) sodium carbonate to the
mixture, total polyphenols were determined after 1 h of incubation in the dark at
room temperature. The absorbance of the reaction mixture was determined at 765
nm against blank sample using a SpectraMax 190 microplate reader (Molecular De-
vices Limited, Berkshire, UK). Quantiﬁcation was done with respect to the standard
curve of Gallic acid and results are expressed as Gallic acid equivalents (GAE).2.4. Determination of a-Amylase inhibitory activity
The a-amylase inhibition assay was adapted from Apostolidis et al. (2006) with
slight modiﬁcations. 40 ml yogurt aqueous extracts and 10 ml a-amylase solution
(0.5 mg/ml) were incubated at 25 C for 10 min. This was followed by the addition
of 100 ml amylase substrate mix (amylase activity assay kit, Sigma-Aldrich, Dorset,
UK). The reaction mixtures were incubated at 25 C for 10 min and the absorbance
were read at 405 nm using a SpectraMax 190 microplate reader (Molecular Devices
Limited, Berkshire, UK). The readings were compared to a control which contained
40 ml of buﬀer solution instead of the extract. The enzyme inhibition was calculated
as below:
Inhibition rate ð%Þ ¼ Absorbance of controlAbsorbance of extracts
Absorbance of control
 100%
2.5. Determination of a-Glucosidase inhibitory activity
The a-glucosidase inhibitory activity was determined according to the method
described by Arce et al. (2016) with slight modiﬁcations. 50 ml yogurt aqueous ex-
tracts and 10 ml a-glucosidase solution (1 U/ml) were incubated at 37 C for 10 min
followed by the addition of 50mL of 0.4 mM/L r-nitrophenyl-a-D-glucopyranoside
(a-NPG) solution in 0.1 mol/L phosphate buﬀer (pH 7.4). After incubated at 37 C
for 15 min, 50 ml of 0.2 mol/L Na2CO3 were added into the reaction mixture to end
the reaction, and its absorbance was measured at 405 nm in a 96 well plate using a
using a SpectraMax 190 microplate reader (Molecular Devices Limited, Berkshire,
UK). The same procedure was followed for the samples which have been previously
fractionated using the Amicon Ultra-0.5 centrifugal ﬁlter devices (3 kDa). The
enzyme inhibition was calculated as below:on.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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Absorbance of control
 100%
The IC50 values (concentrations of supernatants to induce a 50% inhibition of the
enzyme activity) were determined from the equations generated by ﬁtting the data
from the plot of percent a-glucosidase inhibition at week 4 against linear hydrolysate
concentrations ranging from 0.15 to 0.3 mg/mL (ﬁnal assay concentration).2.6. Determination of DPP-IV inhibitory activity
The Dipeptidyl-peptidase 4 (DPP-IV) inhibitory activity was determined using a DPP-
IV inhibitor screeningkit (Sigma-Aldrich,Dorset,UK).Yogurt aqueous extracts (25ml)
were pipetted onto a black 96-well microplate containing the DPP-IV enzyme (50 ml).
This was followed by the addition of 25 ml Enzymatic Reaction Mix, and the ﬂuores-
cence (lex¼ 360/lem¼ 460) was measured every minute on a plate ﬂuorimeter (Spec-
traMax, GEMINIXS,Molecular Devices Ltd.,Wokingham,UK) in kinetic mode at 37
C for 15min. The negative control contained 25ml DPP-IVAssayBuﬀer instead of the
extract. The enzyme inhibition was calculated as below:
Inhibition rate ð%Þ ¼ Slope of control Slope of extracts
Slope of control
 100%
2.7. Degree of hydrolysis
The OPA method was used to determine the degree of hydrolysis (DH) of the yogurt
samples stored for diﬀerent time (Rao et al., 2018). The assay was carried out by
adding 400 ml of sample to 3 ml of OPA reagent. After vortexing, the samples
were incubated for 2 min at room temperature and the absorbance was measured
at 340 nm using a spectrophotometer (SpectraMax 190, Molecular Devices Limited,
Berkshire, UK). L-serine (0.9516 meq/L) was used as positive control and distilled
water as negative control.2.8. Sodium dodecyl sulphate (SDS) polyacrylamide gel
electrophoresis (PAGE)
SDS-PAGE was carried out according to the method described by Laemmli (1970)
using a Mini-Protean 3 electrophoresis cell unit (Bio-Rad, Hertfordshire, UK).
Proteins were analyzed on a 4e20% Mini-Protean TGX precast gel. The migra-
tion buﬀer contained 25 mM Tris, 192 mM glycine and 0.1% SDS (pH 8.3). Super-
natants (aqueous extracts) were diluted (x10) with dH2O and were then dispersed in
an equal volume of sample buﬀer (31.5 mM Tris-HCl, pH 6.8, 10% glycerol, 1%
SDS, 0.005% Bromophenol Blue). Samples were heat-denatured at 100 C for 2
min and 10 ml of each sample were loaded on the gel. SDS-PAGE under reducingon.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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migration was performed at 150 V (constant) for 40 min. The gel was stained
with Coomassie Brilliant Blue R-250 staining solution for 1 h with gentle agitation
and destained for 2 h. The gel was scanned with a GS-800calibrated densitometer
(Bio- Rad, Hertfordshire, UK). Precision Plus Protein unstained standards were
used from protein band identiﬁcation as molecular weight markers (MWM).2.9. Peptide identiﬁcation
2.9.1. Sample preparation
Sample preparation was according to Kunda et al. (2012) with the addition of a size
separation step to select proteins smaller than 3 kDa. Brieﬂy, 0.2 mL yogurt sample
was centrifuged at 12000 x g for 30 min in Amicon Ultra-0.5 centrifugal ﬁlter de-
vice (3 kDa), and the ﬁltrate (<3 kDa) collected. The resulting ﬁltrate was diluted
with 2.5 ml of reduction buﬀer (6 M urea, 5 mM sodium citrate, 5 mM DTT, pH
8.0) and incubated for 1 h at room temperature, followed by centrifugation at
3200 x g for 30 min. Any resulting fat layer was removed by pipetting and the clear
solutions were ﬁltered through 0.22 mm PES (Millex GP ﬁlter Unit, Millipore)
before solid-phase extraction (SPE) with Bond Elut Plexa (Agilent, UK) polymeric
SPE cartridges (60 mg of sorbent). The SPE cartridges were conditioned with 2 mL
of methanol followed by 2 mL of water. Sample (2 mL) was applied to the SPE col-
umn, rinsed with two 1 ml washes (water), and the retained compounds were eluted
with 1 ml of 80:20 (v/v) methanol: water and 0.1% (v/v) of formic acid. Flow rate
was maintained at approximately 1 ml/min during SPE using Cerex System 48 pres-
sure processor. Eluate was evaporated to dryness and ﬁnal residue was reconstituted
with 98% water, 2% acetonitrile, 0.1% formic acid before LC-MS experiments.2.9.2. Proteomics-Q Exactive LC-MS
Peptide samples (puriﬁed by SPE) in 1 mL 80% methanol were dried in a SpeedVac
SC110A (Savant Instruments Pvt. Ltd., Hyderabad, India) and dissolved in 100 mL
0.1% triﬂuoroacetic acid (TFA) for puriﬁcation on ZipTip C18 stage tips (Merck
Millipore, MA, USA) according to the manufacturer’s instructions. Peptides were
eluted in 5 mL 70% acetonitrile, 0.1% TFA in a 96-well format microtitre plate, dried
in a SpeedVac, and dissolved in 10 mL loading solvent for LC-MS analysis. The
LC-MS system comprised a UltiMate 3000 RSLCnano liquid chromatography sys-
tem (Thermo Scientiﬁc Dionex, MA, USA) conﬁgured for pre-concentration onto a
nano column ﬁtted to an EASY-Spray ion source (Thermo Scientiﬁc) and con-
nected to a Q Exactive Plus quadrupole e Orbitrap hybrid mass spectrometer
(Thermo Scientiﬁc). Sample (2 mL) was loaded onto a pre-column (C18 PepMap
100 300 mm i.d. x 5 mm (Thermo Scientiﬁc)) in loading solvent (2% acetonitrile,
0.1% formic acid in water) at 10 mL/min. After 5 min ﬂow through the pre-on.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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column (PepMap RSLC C18 75 mm i.d. x 25 cm (Thermo Scientiﬁc)) at 300 nL/min
using a gradient of acetonitrile in 0.1% formic acid in water. Solvent A was 0.1%
formic acid in water and solvent B was 80% acetonitrile, 0.1% formic acid in water.
The gradient was 3e10% solvent B from 5-10 min, 10e40% solvent B from 10-40
min, 40e80% solvent B from 40-45 min, 80% solvent B from 45-53 min, and ﬁnally
held at 3% solvent B from 54-69 min. The Q Exactive Plus was operated from 5-65
min in full MS/data-dependent MS2 mode using a ‘Top 10’ method. Full MS scans
were performed from 375-1750 m/z with a resolution of 70,000, an automatic gain
control (AGC) target of 3e6, and a maximum injection time (IT) of 50 ms. The 10
most abundant precursor ions with a charge state of þ2 to þ5 were selected from
each MS scan for sequential trapping and fragmentation by higher-energy colli-
sional dissociation (normalized collision energy 26%). MS2 scans were performed
at a resolution of 17,500, an AGC target of 5e4, and a maximum IT of 100 ms. Pre-
viously selected ions were dynamically excluded for 40 s, and peptide ions were
preferred. Q Exactive raw data ﬁles were processed with Proteome Discoverer
v1.4 (Thermo Scientiﬁc) using a workﬂow that included a Mascot v2.5 (Matrix Sci-
ence) and calculation of protein area values based on the extracted ion chromato-
grams of the three most abundant peptides. Searches were carried out against the
Bos taurus sequences (UniProtKB proteome UP000009136) using the following
parameters: Enzyme ¼ none; Maximum missed cleavages ¼ 0; Instrument ¼ FT-
ICR; Precursor mass tolerance¼ 10 ppm; Fragment mass tolerance¼ 20 mmu; Dy-
namic modiﬁcation ¼ Oxidation (M); Static modiﬁcation ¼ none.2.10. Microbiological analysis of yogurt
The most important indices of yogurt microﬂora were measured during the storage
period at days 1, 14, 21 and 28 at 4 C. The total lactic acid bacteria (LAB) were
counted (after appropriate dilutions in Oxoid buﬀered peptone water (CM0509) in
41782 MRS agar (Sigma-Aldrich, Dorset, UK) after incubation at 37 C for 4
days, while Lactobacillus bulgaricus was inoculated in Lactobacillus selective
agar (83920 Rogosa Agar, Sigma-Aldrich, Dorset, UK) and incubated at 37 C
for 4 days, and Streptococcus thermophillus was cultivated in M-17 agar (Sigma-Al-
drich, Dorset, UK) and incubated at 37 C for 2 days. The microbial populations
were analyzed in duplicate and the average values are depicted here.2.11. Statistical analysis
Results are expressed as mean  standard deviation (SD) of at least three replicates.
Statistical analysis of the data was performed using the statistical software SPSS Sta-
tistics 22 (IBM). Data were analyzed by analysis of variance (ANOVA) and signif-
icant diﬀerences (p < 0.05) were detected by the Scheﬀe’s post hoc test.on.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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3.1. Determination of a-amylase and DPP-IV inhibitory activities
Alpha-amylase inhibition is considered an important mechanism involved in the
management of T2 diabetes, which delays carbohydrate digestion by preventing
the breakdown of starch (Saeidnia et al., 2016). Plant proteins and particularly ce-
reals, legumes and wheat, as well as soybean and cumin have been reported to be
the main sources of peptides with a-amylase inhibitory eﬀects (Daliri et al., 2017;
Oseguera-Toledo et al., 2014). Furthermore, a variety of fruits are known to display
a-amylase inhibitory activity, which is attributed to their polyphenolic composition
such as ﬂavonoids and tannins (McDougall et al., 2005). In this study, the a-amylase
inhibition increased signiﬁcantly for all types of yogurt after the fermentation step
compared to the non-fermented samples (baseline) and the inhibitory eﬀect was
further increased during storage at 4 C (Fig. 1A). At day 7, the a-amylase inhibitory
activities of all three samples were over 60%, and remained at this level throughout
the total storage period of 28 days. To the best of our knowledge, the present study is
the ﬁrst to report a-amylase inhibitory activity from fermented milk proteins during
cold storage. This eﬀect may be attributed to the release of peptides with moderate a-
amylase inhibitory activity during cold storage as a result of the continuous proteo-
lytic activity of the lactic acid bacteria. As indicated by Fig. 2, the viability of lactic
acid bacteria was similar for all three types of yogurts and in accordance to the re-
quirements for viable counts in fermented dairy products (>7 log CFU/ml) (OliveiraFig. 1. Alpha-amylase (A), DPP-IV (B) and alpha-glucosidase (C,D) inhibitory activities of yogurt bev-
erages. Each point is the mean of three replicates (n ¼ 3)SE. Diﬀerent letters depict signiﬁcant diﬀer-
ences (P < 0.05) between means for days of storage (per yogurt type). Asterisks depict signiﬁcant
diﬀerences (P < 0.05) between means for yogurt types (per days of storage).
on.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 2. Viable counts of S. thermophilus (A) L. bulgaricus (B) and total lactic acid bacteria (LAB) (C) in
plain and fruit yogurt beverages during 4 weeks of storage at 4 C. Each point is the mean of two rep-
licates (n ¼ 2)SD.
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followed by a decline for L. bulgaricus strain for the remaining of the storage period
and an increase for S. thermophillus during the last week of storage. Our results are
in agreement with previously published data which suggests that viable counts are
higher for S. thermophillus compared with L. bulgaricus, possibly due to the docu-
mented oxygen sensitivity of the latter bacterial strain (Beshkova et al., 2002).
Nevertheless, the total number of lactic acid bacteria decreased during storage and
this eﬀect was more evident for storage periods longer than 14 days (Fig. 2C).
DPP-IV inhibitors enhance the ability to control blood glucose by increasing the
active levels of incretin hormones in the body (Barnett, 2006). Peptides with
documented DPP-IV inhibitory activity can be generated from various foodon.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
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(Patil et al., 2015). In particular, 172 entries for DPP-IV inhibitory peptides (of
which 64 unique sequences) are deposited in the milk bioactive peptide database
(Nielsen et al., 2017). These peptides range from 2 to 14 amino acids in length
and half of the unique sequences have a proline at the second position from the
N-terminal, indicating a possible structural pattern for DPP-IV inhibitory peptides
(Nongonierma and FitzGerald, 2014). Bovine casein proteins and in particular b-
casein has a great potential to serve as precursor for DPP-IV inhibitors due to the
high number of proline residues in the amino acid sequence (Lacroix and Li-
Chan, 2012). In the present study, the DPP-IV inhibitory activities of all types
of yogurt are similar to the a-amylase inhibitory activities (Fig. 1B). The DPP-
IV inhibitory activity signiﬁcantly increased after the fermentation stage and
continued to increase at steady rate during the storage period of 28 days. The
maximum inhibitory eﬀect (>60%) was observed after 21 days of storage for
all three types of yogurt and may be explained by the release of DPP-IV inhibitory
peptides as a result of the hydrolytic action of lactic acid bacteria. In conclusion,
yogurt beverages containing SB and BCP had similar a-amylase and DPP-IV
inhibitory activities with plain yogurt at all sampling points, which suggests
that the addition of fruit extracts had no signiﬁcant eﬀect (P < 0.05) on the
viability of the fermenting bacteria or the release of peptides with a-amylase
and DPP-IV inhibitory activities.3.2. Determination of a-glucosidase inhibitory activity
Alpha-glucosidase is another key enzyme involved in diabetes control, which is
located in the brush border of the enterocytes of the jejunum in the small intestine
and catalyzes the breakdown of carbohydrates by cleaving glycosidic bonds (Yao
et al., 2010). Hence, a-glucosidase inhibitors can retard the release and absorption
of monosaccharides from complex carbohydrates, resulting in reduced postpran-
dial plasma glucose levels. A-glucosidase inhibitors such as acarbose, are
currently used for the treatment of diabetic individuals with postprandial hyper-
glycemia (Patil et al., 2015). As presented in Fig. 1C, all three types of yogurt
exhibited a-glucosidase inhibitory activities, and the inhibitory eﬀect increases
with increasing storage time. During storage time, the a-glucosidase inhibitory ac-
tivity of yogurt beverages containing SB was signiﬁcantly lower (P < 0.05)
compared with the yogurt formulated with BCP (day 7 onwards) and the plain
yogurt (day 14 onwards). At the end of the storage period, the a-glucosidase
inhibitory activities of the yogurt beverages followed the order BC > C >>
SB. The calculated IC50 values of the yogurt beverages (BC ¼ 0.20 mg/ml, C
¼ 0.20 mg/ml and SB ¼ 0.28 mg/ml) were in agreement with this order and
were lower (higher potency) compared to values reported for whey protein hydro-
lysates (Lacroix and Li-Chan, 2013). The exact mechanism by which peptideson.2018.e00875
ors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
censes/by-nc-nd/4.0/).
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saccharide compounds may exert their inhibitory activity by binding to the en-
zyme’s active site via hydrophobic interactions (Bharatham et al., 2008). To
further investigate the eﬀect of the fruit extracts on the observed a-glucosidase
inhibitory activity in yogurt, 10 kDa and 3 kDa centrifugal ﬁlters were used to
fractionate peptides based on their molecular mass. The retentates over 3 kDa
showed no a-glucosidase inhibitory activity for all yogurt types (data not shown),
whereas the 3 kDa ﬁltrates showed similar a-glucosidase inhibitory activities to
the non-ﬁltered samples and followed the same trends with respect to storage
time and fruit speciﬁcity (Fig. 1D). This supports further the hypothesis that
the a-glucosidase inhibitory activity shown by the yogurt samples is primarily
owned to the release of bioactive peptides. The degree of protein hydrolysis
following the fermentation process and during storage of the yogurt beverages
was determined to assess diﬀerences between the samples (Fig. 3). The results
implied that milk protein was gradually hydrolyzed during storage and the degree
of hydrolysis varied depending on the fruit extract. The pattern was consistent
with the results obtained from the a-glucosidase inhibitory activity assay and sug-
gests that the addition of BCP promoted the release of peptides with a-glucosi-
dase inhibitory activity. On the contrary, yogurt beverages with SB were less
susceptible to enzymatic hydrolysis, which may have hindered the release of
bioactive peptides. This eﬀect may be attributed to the formation of complexes
between milk proteins and polyphenols by hydrophobic interactions or hydrogen
bonds (Oliveira et al., 2015). Caseins and whey proteins are known to interact
with plant phenolics, which may induce protein unfolding and the formation of
insoluble complexes (Hasni et al., 2011; Zhang et al., 2014). Furthermore the
complex formation is aﬀected by the phenol concentration, which in turn deter-
mines the extent of the aggregation phenomena (von Staszewksi et al., 2011).
Our results indicate that SB contains signiﬁcantly higher concentration ofFig. 3. Extent of hydrolysis of yogurt beverages during storage at 4 C. Each point is the mean of three
replicates (n ¼ 3)SE. Diﬀerent letters depict signiﬁcant diﬀerences (P < 0.05) between means of each
yogurt type for days of storage (per yogurt type). Asterisks depict signiﬁcant diﬀerences (P < 0.05) be-
tween means for yogurt types (per days of storage).
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7.4M Gallic acid equivalents), which may explain the reduced susceptibility to
proteolytic cleavage for the yogurt beverages with salal fruit. Further evidence
from proteomic analysis of the yogurt samples during storage, suggests that phe-
nols may play a signiﬁcant role in protein structure (Fig. 4). b-lactoglobulin exists
as a mixture of monomers and dimers in the samples and the latter are stabilized
by noncovalent interactions (reducing conditions). At the end of the storage
period, the band corresponding to the dimer cannot be detected for plain yogurt
and the intensity of the band corresponding to the monomer increases
(Fig. 4A). The same but less noticeable eﬀect can be observed for the sample con-
taining BCP (Fig. 4C), whereas the intensity of the dimer band for the yogurt with
SB remains high throughout the storage period (Fig. 4B). Our results suggest that
b-lactoglobulin dimer is more stable in the yogurt sample with SB, possibly due
to increased interactions with phenolic compounds, which may contribute to pro-
tein crosslinking.Fig. 4. Electrophoretic migration pattern analysis of whey proteins and molecular weight markers for
plain (A), SB (B) and BCP (C) yogurt by SDS-PAGE (reducing conditions) during refrigerated storage.
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Exactive LC-MS
Peptidomics is becoming an increasingly valuable tool for the characterization of
food samples including dairy products. It is considered a sub-ﬁeld of proteomics
with a primary focus on the composition, interactions, and properties of peptides pre-
sent in a food matrix (Gagnaire et al., 2009). The recent developments of peptidomic
technology for the identiﬁcation of bioactive peptides from dairy proteins have been
documented in detail (Giacometti and Buretic-Tomljanovic, 2017; Sanchez-Rivera
et al., 2014). Peptidomic approaches have been employed for identifying peptides
in yogurt generated from fermented milk proteins with lactic acid bacteria (Jin
et al., 2016; Kunda et al., 2012). By using diﬀerent combinations of parameters
and milk matrices, various bioactive peptide fragments can be obtained (Bernardi
et al., 2015). In this study, aqueous extracts from berry fruits were used as additional
ingredients for yogurt manufacture. Samples from each yogurt type from the end of
the storage period (4 weeks) were selected for peptidomic analysis. Results revealed
a total 487 peptides of which 161 were common in all types of yogurts (Fig. 5). The
vast majority of the peptides identiﬁed belong to caseins and based on their abun-
dance follow the order: beta-casein, alpha-S1-casein, kappa-casein and alpha-S2-
casein. Peptides from whey proteins were not detected, possibly because at this
pH (4.5), whey proteins are insoluble (isoelectric precipitation). The casein peptides
identiﬁed (407) were screened for bioactivity using the Milk Bioactive Peptide Data-
base (MBPDB, http://mbpdb.nws.oregonstate.edu/) (Nielsen et al., 2017). The
bioactive peptides generated from the diﬀerent types of yogurt are presented in
Table 1. According to the literature, these peptides have ACE-inhibitory or antimi-
crobial activity but no peptides with documented anti-diabetic activity were detected.
The peptides identiﬁed exclusively in yogurt formulated with BCP (potent a-gluco-
sidase inhibitors) are summarized in Table 2. Only two peptides (MPFPKYPVEP
and YQEPVLGPVR) from the list (57 in total) have been identiﬁed as bioactiveFig. 5. Venn diagram of the number of identiﬁed peptides in yogurt beverages.
on.2018.e00875
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Table 1. Bioactive peptides identiﬁed in yogurt drinks using polymeric SPE cartridges.
Protein ID Peptide Protein description Species Intervals Function Reference Control SB BCP
P02666 KYPVEPFTESQSLTL b-casein Bos taurus 128e142 ACE-inhibitory Apostolidis et al. (2006) U U
P33048 TEDELQDKIHPF b-casein Capra hircus 56e67 Antimicrobial Arce et al. (2016) U U U
P33048
P02666
YQEPVLGPVRGPFPI b-casein Capra hircus
Bos taurus
206e220
193e207
Antimicrobial Arce et al. (2016), Barnett, (2006) U U
P02666 YQEPVLGPVRGPFPIIV b-casein Bos taurus 193e209 Immunomodulatory,
Antithrombin, Antimicrobial,
ACE-inhibitory
Apostolidis et al. (2006), Barnett, (2006),
Bernardi et al. (2015), Beshkova et al. (2002)
U U U
P02666 VLPVPQKAVPYPQR b-casein Bos taurus 185e198 Antimicrobial Bharatham et al. (2008) U U U
P02666 LLYQEPVLGPVRGPFPIIV b-casein Bos taurus 206e224 ACE-inhibitory Apostolidis et al. (2006) U U U
P02666 SQSKVLPVPQ b-casein Bos taurus 181e190 ACE-inhibitory Charlton et al. (2002) U U
P02666 LHLPLPL b-casein Bos taurus 148e154 ACE-inhibitory Daliri et al. (2017) U U U
P02666 NLHLPLPLL b-casein Bos taurus 147e155 ACE-inhibitory Deighton et al. (2000) U U U
P33048 PVVVPPFLQPE b-casein Capra hircus 96e106 Antimicrobial Arce et al. (2016) U
P02666 MPFPKYPVEP b-casein Bos taurus 124e133 ACE-inhibitory Charlton et al., (2002) U
P02666 YQEPVLGPVR b-casein Bos taurus 208e217 ACE-inhibitory Gagnaire et al. (2009) U
P02662 VLNENLLR a-S1-casein Bos taurus 30e37 Antimicrobial Gharibzahedi and Chronakis, (2018),
Giacometti and Buretic-Tomljanovic, (2017),
Hasni et al. (2011)
U U
P02663 ALNEINQFYQK a-S2-casein Bos taurus 96e106 ACE-inhibitory Jakobek, (2015) U
P02663 TKVIPYVRYL a-S2-casein Bos taurus 213e222 Antimicrobial Jin et al. (2016) U U U
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Table 2. Peptides identiﬁed exclusively in Blackcurrant pomace yogurt drinks using polymeric SPE cartridges.
n Amino acid sequence Protein precursor Observed mass (Da) Ion m/z Charge Retention time (min) IonScore
1 APKHKEMPFPKYPVEPF b-casein 2042.05 1021.53 2 20.72 60
2 HKEMPFPKYPVEPFTES b-casein 2062.99 1032.00 2 23.18 58
3 MAPKHKEMPFPKYPVEPFT b-casein 2274.14 1137.58 2 20.99 55
4 MHQPHQPLPPTVMFPPQSVL b-casein 2281.16 1141.08 2 27.56 55
5 ENLHLPLPLLQSW b-casein 1559.86 780.43 2 38.70 55
6 MPFPKYPVEPFTESQSLTL b-casein 2211.11 1106.06 2 33.76 54
7 MAPKHKEMPFPKYPVEPFTESQ b-casein 2618.27 1309.64 2 20.97 54
8 EMPFPKYPVEPFTESQSLTLTD b-casein 2572.22 1286.61 2 32.17 54
9 EAMAPKHKEMPFPKYPVEPF b-casein 2373.18 1187.09 2 21.96 53
10 EMPFPKYPVEPFTESQSLTL b-casein 2356.14 1178.57 2 32.79 53
11 LTDVENLHLPLPLLQS b-casein 1802.00 901.52 2 36.62 52
12 LYQEPVLGPVRGPFPII b-casein 1895.08 948.04 2 34.93 52
13 MPFPKYPVEPFTESQSLT b-casein 2098.01 1049.51 2 30.73 51
14 PVVVPPFLQPEVMG b-casein 1508.82 754.91 2 39.33 51
15 VLPVPQKAVPYPQRDMPIQA b-casein 2263.22 1132.11 2 21.65 50
16 SKVLPVPQKAVPYPQRD b-casein 1922.09 641.37 3 17.15 49
17 KEMPFPKYPVEPFTE b-casein 1838.90 919.96 2 25.53 48
18 SLSQSKVLPVPQKAVPYPQR b-casein 2222.26 741.43 3 18.89 47
(continued on next page)
16
https://doi.org/10.1016/j.heliyon.2018.e00875
2405-8440/
2018
T
he
A
uthors.Published
by
E
lsevier
L
td.T
his
is
an
open
access
article
under
the
C
C
B
Y
-N
C
-N
D
license
(http://creativecom
m
ons.org/licenses/by-nc-nd/4.0/).
A
rticle
N
ow
e00875
Table 2. (Continued )
n Amino acid sequence Protein precursor Observed mass (Da) Ion m/z Charge Retention time (min) IonScore
19 MPFPKYPVEPF b-casein 1351.67 676.34 2 29.78 47
20 MPFPKYPVE b-casein 1107.55 554.28 2 23.54 46
21 HPFAQTQSL b-casein 1028.51 514.76 2 16.63 46
22 NLHLPLPLLQSW b-casein 1430.81 715.91 2 38.57 45
23 SLSQSKVLPVPQKAVPYPQRD b-casein 2337.29 585.08 2 19.17 45
24 MPFPKYPVEP b-casein 1204.61 602.81 2 24.73 45
25 YQEPVLGPVR b-casein 1157.63 579.32 2 20.13 44
26 TPVVVPPFLQPEVM b-casein 1568.84 784.92 2 37.21 43
27 FPKYPVEPFTES b-casein 1440.70 720.86 2 25.98 43
28 VLPVPQKAVPYPQRDM b-casein 1837.10 613.34 3 20.96 43
29 PGPIPNSLPQ b-casein 1019.55 510.28 2 24.41 43
30 TDVENLHLPLPLLQS b-casein 1688.92 844.96 2 35.64 43
31 NLHLPLPLLQSWM b-casein 1577.86 789.43 2 37.66 42
32 ENLHLPLPL b-casein 1045.60 523.31 2 53.60 40
33 LGPVRGPFPIIV b-casein 1264.78 632.89 2 31.87 35
34 SDIPNPIGSE a-s1-casein 1028.49 514.75 2 24.38 59
35 FFVAPFPEVFGKEKV a-s1-casein 1740.93 580.98 3 30.71 50
36 SFSDIPNPIGSENSEK a-s1-casein 1720.80 860.90 2 23.86 46
37 YTDAPSFSDIPNPIGSEN a-s1-casein 1923.86 962.43 2 32.52 46
(continued on next page)
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Table 2. (Continued )
n Amino acid sequence Protein precursor Observed mass (Da) Ion m/z Charge Retention time (min) IonScore
38 PFPEVFGKEKV a-s1-casein 1276.69 638.85 2 23.80 45
39 APFPEVFGKEK a-s1-casein 1248.66 624.84 2 26.12 44
40 FPEVFGKEKVN a-s1-casein 1293.68 431.90 3 19.31 43
41 YGLNYYQQKPVAL k-casein 1556.81 778.91 2 24.61 56
42 QYVLSRYPSYGLNYYQQKPV k-casein 2466.24 822.75 3 24.40 54
43 PSYGLNYYQQKPVAL k-casein 1740.90 870.95 2 25.31 51
44 YYQQKPVALINNQFLPYPYYAKPA k-casein 2889.49 963.83 3 29.07 51
45 VLSRYPSYGLNYYQQKPV k-casein 2175.12 725.71 3 22.12 51
46 SRYPSYGLNYYQQKP k-casein 1863.90 621.97 3 19.26 51
47 SRYPSYGLNYYQQKPVALINN k-casein 2488.27 830.09 3 24.38 48
48 NQFLPYPYYA k-casein 1275.60 638.30 2 32.83 47
49 INNQFLPYPYYAKPAAVRSPAQ k-casein 2508.30 836.77 3 24.63 46
50 SRYPSYGLN k-casein 1056.51 528.76 2 17.32 42
51 LPYPYYAKPA k-casein 1182.61 591.81 2 20.78 42
52 ALNEINQFYQKFPQ a-s2-casein 1739.88 870.44 2 27.53 52
53 EINQFYQKFPQ a-s2-casein 1441.71 721.36 2 23.57 52
54 LPQYLKTVYQ a-s2-casein 1252.69 626.85 2 23.14 47
55 NAVPITPTLNREQ a-s2-casein 1452.78 726.89 2 19.79 42
56 NAVPITPTLNREQL a-s2-casein 1565.87 783.44 2 23.63 41
57 KVIPYVRYL a-s2-casein 1150.70 575.85 2 21.95 41
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tides identiﬁed in BCP yogurt is required to assess their potential as a-glucosidase
inhibitors.4. Conclusions
The present study adopted a bioactive peptide approach to investigate the potential
of adding aqueous berry extracts to the yogurt matrix for the development of a
beverage with anti-diabetic properties. Results demonstrated that enzyme inhibition
(a-amylase, a-glucosidase and DPP-IV) increases with storage time at 4 C, regard-
less the yogurt type. These ﬁndings suggest that yogurt may have the potential to
improve blood glucose regulation by means of its ability to slow both the inactiva-
tion of the incretin hormones and the intestinal digestion of carbohydrates. The
beverage formulated with BCP showed the highest potential for inhibiting the activ-
ity of a-glucosidase, which is possibly due to the peptides released from caseins dur-
ing the fermentation process. Diﬀerences in a-glucosidase inhibition between
yogurts with BPC and SB extracts are attributed to the formation of complexes be-
tween milk proteins and phenolic compounds for the latter, which may induce
changes in protein conformation and can aﬀect the susceptibility to enzymatic hy-
drolysis by lactic acid bacteria. Further research is needed to assess the bioactivity
of the peptides generated in yogurt with BCP and particularly their potential as a-
glucosidase inhibitors. In addition, once the bioactivity of the reformulated yogurts
has been established, the eﬀects on sensory attributes will need to be evaluated. This
will require an instrumental approach to determine microstructural and rheological
properties as well as consumer-based studies to obtain essential information on sen-
sory perception in the initial stages of product reformulation.Declarations
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